Hologic (HOLX) Tops Q2 EPS by 2c; Guides Q3 Lower

Hologic (NASDAQ: HOLX) reported Q2 EPS of $2.59, $0.02 better than the analyst estimate of $2.57. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.53 billion.

“Hologic posted very strong financial results in our second fiscal quarter in line with our guidance,” said Steve MacMillan, the Company’s chairman, president and chief executive officer. “Organic revenue doubled, driven by strong recovery and momentum in our base businesses, as well as our continued response to the COVID-19 pandemic. And earnings per share more than quadrupled. We also used our strong cash flows to complete three acquisitions and announce another, which we believe will accelerate our growth and make us a stronger company post-pandemic.”

GUIDANCE:

Hologic sees Q3 2021 EPS of $1.00-$1.15, versus the consensus of $1.83. Hologic sees Q3 2021 revenue of $1-1.07 billion, versus the consensus of $1.29 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• C.H. Robinson acquires DeSpir Logistics for $75 million